Information and education gap in substance abuse treatment

People struggling with substance abuse lack access to information about treatment options, success stories, and evidence-based recovery pathways. This creates barriers to seeking help and understanding what medications/therapies might work.

YC GraveyardJun 1, 2019ToolMedicine & HealthSource

FL score

out of 100

Verdict

VALIDATE

high confidence

Competition

competitors found, emerging market, funded players

Trend

No signal yet

An AI-powered transparent treatment guide for individuals and families navigating substance abuse options, addressing a critical information gap where funded solutions have struggled.

The pain

People struggling with substance abuse and their families lack clear, accessible, and evidence-based information about treatment options, success stories, and recovery pathways. This leads to confusion, delayed help-seeking, and difficulty understanding which therapies or medications might work for them.

The gap

Current solutions are often B2B, have failed (e.g., Pear Therapeutics' reimbursement issues, Sober Grid shutting down), or are full treatment providers. There's a clear whitespace for an independent, AI-powered information platform that acts as a transparent guide for individuals, addressing specific frustrations like opaque pricing, short treatment durations, and lack of a non-prescription info hub.

Build angle

Develop an AI-powered content platform offering personalized recovery education, a treatment option matching tool, a comprehensive provider directory, and a community resource aggregator. Position it as a 'transparent treatment guide' specifically for individuals and families, rather than a treatment provider or medication company.

Strengths

Addresses a real, severe, and widely discussed problem with life-altering implications.
Clear market gap for an unbiased, individual-focused information platform.

Questions about this idea?

FlyBot reads the scoring and gives you a second opinion on “Information and education gap in substance abuse treatment”.

Open FlyBot

Next steps

Conduct in-depth user interviews with individuals and families impacted by substance abuse to validate specific information needs and willingness to pay for a curated, trusted guide.
Explore partnerships with non-profits, support groups, or smaller treatment centers to understand potential B2B2C models for distribution and monetization.
Develop a clear content strategy and identify sources for evidence-based information, considering how to ensure medical accuracy and build trust.
Create a simple landing page or waitlist to gauge interest for a specific 'treatment guide' focusing on one type of substance (e.g., opioid use disorder) and test different pricing models for premium information/matching features.

Fly Labs Method

Is the pain real, is there a gap, is it the right time, can one person build it.

Problem clarity: 26
Solution gap: 23
Willingness to pay: 19
Buildability: 9

This idea addresses a real, severe pain point with a clear market gap for an unbiased, individual-focused information platform. However, the buildability for a solo builder is challenging, and direct willingness to pay for information needs more validation.

Value Equation

Dream outcome and how likely it feels, against the time and effort it costs.

Strong market need and growth, but challenges in direct monetization for an information product and the complexity of building trust and a robust platform for a solo builder.

One-Person Business

Curiosity pull, identity fit, and a path from free value to paid for a solo creator.

Clear problem with a good niche, but demands significant creator expertise, poses complexity in building and requires careful monetization strategy to overcome the expectation of free medical information.

Viral Frameworks

Hook strength, shareability, and how cheaply it can be tested.

Clear value proposition and target audience, but distribution, monetization, and validating willingness to pay for medical information are significant risks that need careful validation.

Builder Lens

Evidence the problem exists, timing, defensibility, and a model that fits on a napkin.

Strong demand for a better solution in a critical area, but building trust, navigating a sensitive market, and finding a sustainable narrow wedge are key challenges.

Why this verdict

The idea tackles a profoundly important problem with a strong underlying need for better information, and the solo builder angle smartly avoids the capital-intensive pitfalls of past failures. However, the unique challenges of building a trusted health-related product as a solo founder, the ongoing need for accurate medical content, and the critical question of whether users will pay for information in this domain mean that robust validation is essential before committing to a full build. While the potential is high, the execution risks for a solo builder are significant without prior domain expertise or strong partnerships.

Five lenses, one composite. How scoring works

The angle

This weekend

Conduct in-depth user interviews with individuals and families impacted by substance abuse to validate specific information needs and willingness to pay for a curated, trusted guide.
Explore partnerships with non-profits, support groups, or smaller treatment centers to understand potential B2B2C models for distribution and monetization.
Develop a clear content strategy and identify sources for evidence-based information, considering how to ensure medical accuracy and build trust.
Create a simple landing page or waitlist to gauge interest for a specific 'treatment guide' focusing on one type of substance (e.g., opioid use disorder) and test different pricing models for premium information/matching features.

Who is already there, emerging market

Eleos HealthFundedVisit
Eleos Health offers an AI-powered platform for behavioral health providers to automate clinical documentation and compliance checks, aiming to reduce administrative burdens and enhance care.
Pricing: Not publicly available; focuses on enterprise solutions for large organizations, hospitals, and multi-site agencies.
Pear TherapeuticsFundedVisit
Pear Therapeutics developed FDA-cleared prescription digital therapeutics (PDTs) for substance use disorder (reSET) and opioid use disorder (reSET-O), delivering cognitive behavioral therapy via a mobile app.
Pricing: Average selling price of $1,195, but reimbursement was a significant challenge, only covered in about ten states.
Sober GridFundedVisit
Sober Grid was a mobile application that provided peer support and resources for individuals in recovery from substance use disorders, connecting users based on geolocation and offering features like a newsfeed and chat.
Pricing: Free app with peer recovery coaching features costing typically $99 per month after a two-week free trial.
Boulder CareFundedVisit
Boulder Care provides virtual addiction treatment for opioid and alcohol use disorder, offering access to peer recovery specialists, clinicians, and medication-assisted treatment via an app-based program.
Pricing: Not publicly available, as they primarily work with payers, especially Medicaid, in value-based contracts.
Lucid LaneFundedVisit
Lucid Lane is a telehealth solution that empowers people with medication dependence and substance-use disorders, providing ongoing measurement, monitoring, personalized treatment planning, and timely interventions.
Pricing: Not publicly available.
DynamiCare HealthFundedVisit
DynamiCare Health offers a digital therapeutics platform for substance use disorders that focuses on contingency management (CM) with financial incentives and integrates cognitive behavioral therapy (CBT).
Pricing: Not publicly available, but emphasizes cost-effectiveness and scalability without requiring clinician supervision for some aspects.

Funded players

What they charge

The pricing landscape for substance abuse treatment solutions varies. Some apps, like Sober Grid, offered a free tier for basic peer support with a monthly subscription fee for premium features like peer recovery coaching ($99/month). Prescription digital therapeutics, like those from Pear Therapeutics, had an average selling price of $1,195, but struggled with reimbursement. Other solutions, particularly those focused on enterprise or working with payers (e.g., Eleos Health, Boulder Care, Lucid Lane), do not publicly disclose their pricing, indicating a B2B sales model likely involving custom contracts or per-member-per-month (PMPM) fees. The market also sees free resources and grant-funded programs to increase accessibility.

Information and education gap in substance abuse treatment

Preventive and restorative tooth care alternatives to root canal

Fertility tracking and ovulation prediction through accessible testing

Asynchronous telemedicine for chronic dermatology conditions